What Are SGLT2 Inhibitors? Safety and Efficacy Data for a New and Exciting Treatment

There are new and exciting treatments available for feline diabetes mellitus. In this lecture, we will introduce the most successful oral treatment for feline diabetes, the sodium glucose transporter 2 (SGLT-2) inhibitors. We will reveal safety and efficacy data regarding velagliflozin, an SGLT-2 inhibitor recently studied in cats. This option represents a true paradigm shift in the management of feline diabetes.

Learning Objectives:
o 1. Participants will be able to describe the mechanism of action of the SGLT2 inhibitor drug class.
o 2. The practitioner will be able to state the efficacy of velagliflozin, an SGLT2 inhibitor, in diabetic cats with regard to glycemic parameters and clinical signs.
o 3. The practitioner will be able to state the safety data of velagliflozin in diabetic cats and their relative importance